SCHEMBL3754652

SCHEMBL3754652

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3cccc(CN)c3)c2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.40
PIK3CD O00329 3/20 0.40
PIK3CG P48736 3/20 0.40
PIK3CB P42338 2/20 0.40
BRD4 O60885 1/20 0.38
NCF1 P14598 1/20 0.37
AOC3 Q16853 5/20 0.37
PRKDC P78527 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 3/20 0.35
KDM4E B2RXH2 2/20 0.35
GLA P06280 2/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759987 0.92 BUB1 (0.36) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3759346 0.89 AOC3 (0.39) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3758928 0.88 ALDH1A1 (0.39) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3764864 0.87 PIK3CA (0.42) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3759330 0.87 PSMB8 (0.41) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3751935 0.87 AOC3 (0.40) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3757704 0.86 PIK3CD (0.42) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3758948 0.86 PIK3CD (0.42) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3756166 0.86 AOC3 (0.39) PIK3CAPIK3CDPIK3CGPIK3CBBRD4
SCHEMBL3760569 0.85 PRKDC (0.46) PIK3CAPIK3CDPIK3CGPIK3CBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CG 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.